24 results

An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA

Rejeski, Kai; Greco, Raffaella; Onida, Francesco; More

HemaSphere. 7(5):e889, May 2023.

Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL

Rejeski, Kai; Blumenberg, Viktoria; Iacoboni, Gloria; More

HemaSphere. 7(4):e858, April 2023.

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis

Hermans, Sjoerd J. F.; Versluis, Jurjen; Labopin, Myriam; More

HemaSphere. 7(3):e846, March 2023.

Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice

Delforge, Michel; Vekemans, Marie-Christiane; Depaus, Julien; More

HemaSphere. 6(12):e813, December 2022.

CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS

Rösler, Wiebke; Bink, Andrea; Bissig, Marina; More

HemaSphere. 6(7):e733, July 2022.

Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease

Zelic Kerep, Ana; Pirsl, Filip; Steinberg, Seth; More

HemaSphere. 6(6):e730, June 2022.

Second Solid Cancers After Hematopoietic Stem Cell Transplantation: Active Surveillance During Long-term Follow-up

Lupo-Stanghellini, Maria Teresa; Piemontese, Simona; Assanelli, Andrea; More

HemaSphere. 5(11):e654, November 2021.

CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an “Off the Shelf” Therapy for Multiple Myeloma

Stikvoort, Arwen; van der Schans, Jort; Sarkar, Subhashis; More

HemaSphere. 5(7):e596, July 2021.

Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant

Holthof, Lisa C.; Stikvoort, Arwen; van der Horst, Hilma J.; More

HemaSphere. 5(5):e561, May 2021.

Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm

Baronciani, Donatella; Casale, Maddalena; De Franceschi, Lucia; More

HemaSphere. 5(5):e555, May 2021.

Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells

Karschnia, Philipp; Strübing, Felix; Teske, Nico; More

HemaSphere. 5(3):e533, March 2021.

Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions

Valent, Peter; Orfao, Alberto; Kubicek, Stefan; More

HemaSphere. 5(3):e536, March 2021.

Human Herpesvirus 6 Encephalitis Following Axicabtagene Ciloleucel Treatment for Refractory Diffuse Large B Cell Lymphoma

Shah, Mili; Kuhnl, Andrea; Shields, Gregory; More

HemaSphere. 5(3):e535, March 2021.